Guillain-Barr? Syndrome Market, Global Outlook and Forecast 2022-2028
Guillain-Barr? Syndrome is a rapid-onset muscle weakness caused by the immune system damaging the peripheral nervous system.
This report contains market size and forecasts of Guillain-Barr? Syndrome in Global, including the following market information:
Global Guillain-Barr? Syndrome Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Guillain-Barr? Syndrome market was valued at 448.3 million in 2021 and is projected to reach US$ 539.5 million by 2028, at a CAGR of 2.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Intravenous Immunoglobulin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Guillain-Barr? Syndrome include Grifols, CSL Behring, Octapharma, Nihon Pharmaceutical, Akari Therapeutics, China Biologic Products Holdings, Biotest and Kedrion, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Guillain-Barr? Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Guillain-Barr? Syndrome Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Guillain-Barr? Syndrome Market Segment Percentages, by Type, 2021 (%)
Global Guillain-Barr? Syndrome Market Segment Percentages, by Application, 2021 (%)
Global Guillain-Barr? Syndrome Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Guillain-Barr? Syndrome revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Guillain-Barr? Syndrome revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Guillain-Barr? Syndrome in Global, including the following market information:
Global Guillain-Barr? Syndrome Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Guillain-Barr? Syndrome market was valued at 448.3 million in 2021 and is projected to reach US$ 539.5 million by 2028, at a CAGR of 2.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Intravenous Immunoglobulin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Guillain-Barr? Syndrome include Grifols, CSL Behring, Octapharma, Nihon Pharmaceutical, Akari Therapeutics, China Biologic Products Holdings, Biotest and Kedrion, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Guillain-Barr? Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Guillain-Barr? Syndrome Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Guillain-Barr? Syndrome Market Segment Percentages, by Type, 2021 (%)
- Intravenous Immunoglobulin
- Plasma Exchange
- Others
Global Guillain-Barr? Syndrome Market Segment Percentages, by Application, 2021 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Others
Global Guillain-Barr? Syndrome Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Guillain-Barr? Syndrome revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Guillain-Barr? Syndrome revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Grifols
- CSL Behring
- Octapharma
- Nihon Pharmaceutical
- Akari Therapeutics
- China Biologic Products Holdings
- Biotest
- Kedrion
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Guillain-Barr? Syndrome Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Guillain-Barr? Syndrome Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GUILLAIN-BARR? SYNDROME OVERALL MARKET SIZE
2.1 Global Guillain-Barr? Syndrome Market Size: 2021 VS 2028
2.2 Global Guillain-Barr? Syndrome Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Guillain-Barr? Syndrome Players in Global Market
3.2 Top Global Guillain-Barr? Syndrome Companies Ranked by Revenue
3.3 Global Guillain-Barr? Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Guillain-Barr? Syndrome Companies in Global Market, by Revenue in 2021
3.5 Global Companies Guillain-Barr? Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Guillain-Barr? Syndrome Players in Global Market
3.6.1 List of Global Tier 1 Guillain-Barr? Syndrome Companies
3.6.2 List of Global Tier 2 and Tier 3 Guillain-Barr? Syndrome Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Guillain-Barr? Syndrome Market Size Markets, 2021 & 2028
4.1.2 Intravenous Immunoglobulin
4.1.3 Plasma Exchange
4.1.4 Others
4.2 By Type - Global Guillain-Barr? Syndrome Revenue & Forecasts
4.2.1 By Type - Global Guillain-Barr? Syndrome Revenue, 2017-2022
4.2.2 By Type - Global Guillain-Barr? Syndrome Revenue, 2023-2028
4.2.3 By Type - Global Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Guillain-Barr? Syndrome Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Others
5.2 By Application - Global Guillain-Barr? Syndrome Revenue & Forecasts
5.2.1 By Application - Global Guillain-Barr? Syndrome Revenue, 2017-2022
5.2.2 By Application - Global Guillain-Barr? Syndrome Revenue, 2023-2028
5.2.3 By Application - Global Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Guillain-Barr? Syndrome Market Size, 2021 & 2028
6.2 By Region - Global Guillain-Barr? Syndrome Revenue & Forecasts
6.2.1 By Region - Global Guillain-Barr? Syndrome Revenue, 2017-2022
6.2.2 By Region - Global Guillain-Barr? Syndrome Revenue, 2023-2028
6.2.3 By Region - Global Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Guillain-Barr? Syndrome Revenue, 2017-2028
6.3.2 US Guillain-Barr? Syndrome Market Size, 2017-2028
6.3.3 Canada Guillain-Barr? Syndrome Market Size, 2017-2028
6.3.4 Mexico Guillain-Barr? Syndrome Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Guillain-Barr? Syndrome Revenue, 2017-2028
6.4.2 Germany Guillain-Barr? Syndrome Market Size, 2017-2028
6.4.3 France Guillain-Barr? Syndrome Market Size, 2017-2028
6.4.4 U.K. Guillain-Barr? Syndrome Market Size, 2017-2028
6.4.5 Italy Guillain-Barr? Syndrome Market Size, 2017-2028
6.4.6 Russia Guillain-Barr? Syndrome Market Size, 2017-2028
6.4.7 Nordic Countries Guillain-Barr? Syndrome Market Size, 2017-2028
6.4.8 Benelux Guillain-Barr? Syndrome Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Guillain-Barr? Syndrome Revenue, 2017-2028
6.5.2 China Guillain-Barr? Syndrome Market Size, 2017-2028
6.5.3 Japan Guillain-Barr? Syndrome Market Size, 2017-2028
6.5.4 South Korea Guillain-Barr? Syndrome Market Size, 2017-2028
6.5.5 Southeast Asia Guillain-Barr? Syndrome Market Size, 2017-2028
6.5.6 India Guillain-Barr? Syndrome Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Guillain-Barr? Syndrome Revenue, 2017-2028
6.6.2 Brazil Guillain-Barr? Syndrome Market Size, 2017-2028
6.6.3 Argentina Guillain-Barr? Syndrome Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Guillain-Barr? Syndrome Revenue, 2017-2028
6.7.2 Turkey Guillain-Barr? Syndrome Market Size, 2017-2028
6.7.3 Israel Guillain-Barr? Syndrome Market Size, 2017-2028
6.7.4 Saudi Arabia Guillain-Barr? Syndrome Market Size, 2017-2028
6.7.5 UAE Guillain-Barr? Syndrome Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Grifols
7.1.1 Grifols Corporate Summary
7.1.2 Grifols Business Overview
7.1.3 Grifols Guillain-Barr? Syndrome Major Product Offerings
7.1.4 Grifols Guillain-Barr? Syndrome Revenue in Global Market (2017-2022)
7.1.5 Grifols Key News
7.2 CSL Behring
7.2.1 CSL Behring Corporate Summary
7.2.2 CSL Behring Business Overview
7.2.3 CSL Behring Guillain-Barr? Syndrome Major Product Offerings
7.2.4 CSL Behring Guillain-Barr? Syndrome Revenue in Global Market (2017-2022)
7.2.5 CSL Behring Key News
7.3 Octapharma
7.3.1 Octapharma Corporate Summary
7.3.2 Octapharma Business Overview
7.3.3 Octapharma Guillain-Barr? Syndrome Major Product Offerings
7.3.4 Octapharma Guillain-Barr? Syndrome Revenue in Global Market (2017-2022)
7.3.5 Octapharma Key News
7.4 Nihon Pharmaceutical
7.4.1 Nihon Pharmaceutical Corporate Summary
7.4.2 Nihon Pharmaceutical Business Overview
7.4.3 Nihon Pharmaceutical Guillain-Barr? Syndrome Major Product Offerings
7.4.4 Nihon Pharmaceutical Guillain-Barr? Syndrome Revenue in Global Market (2017-2022)
7.4.5 Nihon Pharmaceutical Key News
7.5 Akari Therapeutics
7.5.1 Akari Therapeutics Corporate Summary
7.5.2 Akari Therapeutics Business Overview
7.5.3 Akari Therapeutics Guillain-Barr? Syndrome Major Product Offerings
7.5.4 Akari Therapeutics Guillain-Barr? Syndrome Revenue in Global Market (2017-2022)
7.5.5 Akari Therapeutics Key News
7.6 China Biologic Products Holdings
7.6.1 China Biologic Products Holdings Corporate Summary
7.6.2 China Biologic Products Holdings Business Overview
7.6.3 China Biologic Products Holdings Guillain-Barr? Syndrome Major Product Offerings
7.6.4 China Biologic Products Holdings Guillain-Barr? Syndrome Revenue in Global Market (2017-2022)
7.6.5 China Biologic Products Holdings Key News
7.7 Biotest
7.7.1 Biotest Corporate Summary
7.7.2 Biotest Business Overview
7.7.3 Biotest Guillain-Barr? Syndrome Major Product Offerings
7.7.4 Biotest Guillain-Barr? Syndrome Revenue in Global Market (2017-2022)
7.7.5 Biotest Key News
7.8 Kedrion
7.8.1 Kedrion Corporate Summary
7.8.2 Kedrion Business Overview
7.8.3 Kedrion Guillain-Barr? Syndrome Major Product Offerings
7.8.4 Kedrion Guillain-Barr? Syndrome Revenue in Global Market (2017-2022)
7.8.5 Kedrion Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Guillain-Barr? Syndrome Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Guillain-Barr? Syndrome Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GUILLAIN-BARR? SYNDROME OVERALL MARKET SIZE
2.1 Global Guillain-Barr? Syndrome Market Size: 2021 VS 2028
2.2 Global Guillain-Barr? Syndrome Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Guillain-Barr? Syndrome Players in Global Market
3.2 Top Global Guillain-Barr? Syndrome Companies Ranked by Revenue
3.3 Global Guillain-Barr? Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Guillain-Barr? Syndrome Companies in Global Market, by Revenue in 2021
3.5 Global Companies Guillain-Barr? Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Guillain-Barr? Syndrome Players in Global Market
3.6.1 List of Global Tier 1 Guillain-Barr? Syndrome Companies
3.6.2 List of Global Tier 2 and Tier 3 Guillain-Barr? Syndrome Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Guillain-Barr? Syndrome Market Size Markets, 2021 & 2028
4.1.2 Intravenous Immunoglobulin
4.1.3 Plasma Exchange
4.1.4 Others
4.2 By Type - Global Guillain-Barr? Syndrome Revenue & Forecasts
4.2.1 By Type - Global Guillain-Barr? Syndrome Revenue, 2017-2022
4.2.2 By Type - Global Guillain-Barr? Syndrome Revenue, 2023-2028
4.2.3 By Type - Global Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Guillain-Barr? Syndrome Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Others
5.2 By Application - Global Guillain-Barr? Syndrome Revenue & Forecasts
5.2.1 By Application - Global Guillain-Barr? Syndrome Revenue, 2017-2022
5.2.2 By Application - Global Guillain-Barr? Syndrome Revenue, 2023-2028
5.2.3 By Application - Global Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Guillain-Barr? Syndrome Market Size, 2021 & 2028
6.2 By Region - Global Guillain-Barr? Syndrome Revenue & Forecasts
6.2.1 By Region - Global Guillain-Barr? Syndrome Revenue, 2017-2022
6.2.2 By Region - Global Guillain-Barr? Syndrome Revenue, 2023-2028
6.2.3 By Region - Global Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Guillain-Barr? Syndrome Revenue, 2017-2028
6.3.2 US Guillain-Barr? Syndrome Market Size, 2017-2028
6.3.3 Canada Guillain-Barr? Syndrome Market Size, 2017-2028
6.3.4 Mexico Guillain-Barr? Syndrome Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Guillain-Barr? Syndrome Revenue, 2017-2028
6.4.2 Germany Guillain-Barr? Syndrome Market Size, 2017-2028
6.4.3 France Guillain-Barr? Syndrome Market Size, 2017-2028
6.4.4 U.K. Guillain-Barr? Syndrome Market Size, 2017-2028
6.4.5 Italy Guillain-Barr? Syndrome Market Size, 2017-2028
6.4.6 Russia Guillain-Barr? Syndrome Market Size, 2017-2028
6.4.7 Nordic Countries Guillain-Barr? Syndrome Market Size, 2017-2028
6.4.8 Benelux Guillain-Barr? Syndrome Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Guillain-Barr? Syndrome Revenue, 2017-2028
6.5.2 China Guillain-Barr? Syndrome Market Size, 2017-2028
6.5.3 Japan Guillain-Barr? Syndrome Market Size, 2017-2028
6.5.4 South Korea Guillain-Barr? Syndrome Market Size, 2017-2028
6.5.5 Southeast Asia Guillain-Barr? Syndrome Market Size, 2017-2028
6.5.6 India Guillain-Barr? Syndrome Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Guillain-Barr? Syndrome Revenue, 2017-2028
6.6.2 Brazil Guillain-Barr? Syndrome Market Size, 2017-2028
6.6.3 Argentina Guillain-Barr? Syndrome Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Guillain-Barr? Syndrome Revenue, 2017-2028
6.7.2 Turkey Guillain-Barr? Syndrome Market Size, 2017-2028
6.7.3 Israel Guillain-Barr? Syndrome Market Size, 2017-2028
6.7.4 Saudi Arabia Guillain-Barr? Syndrome Market Size, 2017-2028
6.7.5 UAE Guillain-Barr? Syndrome Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Grifols
7.1.1 Grifols Corporate Summary
7.1.2 Grifols Business Overview
7.1.3 Grifols Guillain-Barr? Syndrome Major Product Offerings
7.1.4 Grifols Guillain-Barr? Syndrome Revenue in Global Market (2017-2022)
7.1.5 Grifols Key News
7.2 CSL Behring
7.2.1 CSL Behring Corporate Summary
7.2.2 CSL Behring Business Overview
7.2.3 CSL Behring Guillain-Barr? Syndrome Major Product Offerings
7.2.4 CSL Behring Guillain-Barr? Syndrome Revenue in Global Market (2017-2022)
7.2.5 CSL Behring Key News
7.3 Octapharma
7.3.1 Octapharma Corporate Summary
7.3.2 Octapharma Business Overview
7.3.3 Octapharma Guillain-Barr? Syndrome Major Product Offerings
7.3.4 Octapharma Guillain-Barr? Syndrome Revenue in Global Market (2017-2022)
7.3.5 Octapharma Key News
7.4 Nihon Pharmaceutical
7.4.1 Nihon Pharmaceutical Corporate Summary
7.4.2 Nihon Pharmaceutical Business Overview
7.4.3 Nihon Pharmaceutical Guillain-Barr? Syndrome Major Product Offerings
7.4.4 Nihon Pharmaceutical Guillain-Barr? Syndrome Revenue in Global Market (2017-2022)
7.4.5 Nihon Pharmaceutical Key News
7.5 Akari Therapeutics
7.5.1 Akari Therapeutics Corporate Summary
7.5.2 Akari Therapeutics Business Overview
7.5.3 Akari Therapeutics Guillain-Barr? Syndrome Major Product Offerings
7.5.4 Akari Therapeutics Guillain-Barr? Syndrome Revenue in Global Market (2017-2022)
7.5.5 Akari Therapeutics Key News
7.6 China Biologic Products Holdings
7.6.1 China Biologic Products Holdings Corporate Summary
7.6.2 China Biologic Products Holdings Business Overview
7.6.3 China Biologic Products Holdings Guillain-Barr? Syndrome Major Product Offerings
7.6.4 China Biologic Products Holdings Guillain-Barr? Syndrome Revenue in Global Market (2017-2022)
7.6.5 China Biologic Products Holdings Key News
7.7 Biotest
7.7.1 Biotest Corporate Summary
7.7.2 Biotest Business Overview
7.7.3 Biotest Guillain-Barr? Syndrome Major Product Offerings
7.7.4 Biotest Guillain-Barr? Syndrome Revenue in Global Market (2017-2022)
7.7.5 Biotest Key News
7.8 Kedrion
7.8.1 Kedrion Corporate Summary
7.8.2 Kedrion Business Overview
7.8.3 Kedrion Guillain-Barr? Syndrome Major Product Offerings
7.8.4 Kedrion Guillain-Barr? Syndrome Revenue in Global Market (2017-2022)
7.8.5 Kedrion Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Guillain-Barr? Syndrome Market Opportunities & Trends in Global Market
Table 2. Guillain-Barr? Syndrome Market Drivers in Global Market
Table 3. Guillain-Barr? Syndrome Market Restraints in Global Market
Table 4. Key Players of Guillain-Barr? Syndrome in Global Market
Table 5. Top Guillain-Barr? Syndrome Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Guillain-Barr? Syndrome Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Guillain-Barr? Syndrome Revenue Share by Companies, 2017-2022
Table 8. Global Companies Guillain-Barr? Syndrome Product Type
Table 9. List of Global Tier 1 Guillain-Barr? Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Guillain-Barr? Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Guillain-Barr? Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Guillain-Barr? Syndrome Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Guillain-Barr? Syndrome Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Guillain-Barr? Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Guillain-Barr? Syndrome Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Guillain-Barr? Syndrome Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Guillain-Barr? Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Guillain-Barr? Syndrome Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Guillain-Barr? Syndrome Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Guillain-Barr? Syndrome Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Guillain-Barr? Syndrome Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Guillain-Barr? Syndrome Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Guillain-Barr? Syndrome Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Guillain-Barr? Syndrome Revenue, (US$, Mn), 2023-2028
Table 30. Grifols Corporate Summary
Table 31. Grifols Guillain-Barr? Syndrome Product Offerings
Table 32. Grifols Guillain-Barr? Syndrome Revenue (US$, Mn), (2017-2022)
Table 33. CSL Behring Corporate Summary
Table 34. CSL Behring Guillain-Barr? Syndrome Product Offerings
Table 35. CSL Behring Guillain-Barr? Syndrome Revenue (US$, Mn), (2017-2022)
Table 36. Octapharma Corporate Summary
Table 37. Octapharma Guillain-Barr? Syndrome Product Offerings
Table 38. Octapharma Guillain-Barr? Syndrome Revenue (US$, Mn), (2017-2022)
Table 39. Nihon Pharmaceutical Corporate Summary
Table 40. Nihon Pharmaceutical Guillain-Barr? Syndrome Product Offerings
Table 41. Nihon Pharmaceutical Guillain-Barr? Syndrome Revenue (US$, Mn), (2017-2022)
Table 42. Akari Therapeutics Corporate Summary
Table 43. Akari Therapeutics Guillain-Barr? Syndrome Product Offerings
Table 44. Akari Therapeutics Guillain-Barr? Syndrome Revenue (US$, Mn), (2017-2022)
Table 45. China Biologic Products Holdings Corporate Summary
Table 46. China Biologic Products Holdings Guillain-Barr? Syndrome Product Offerings
Table 47. China Biologic Products Holdings Guillain-Barr? Syndrome Revenue (US$, Mn), (2017-2022)
Table 48. Biotest Corporate Summary
Table 49. Biotest Guillain-Barr? Syndrome Product Offerings
Table 50. Biotest Guillain-Barr? Syndrome Revenue (US$, Mn), (2017-2022)
Table 51. Kedrion Corporate Summary
Table 52. Kedrion Guillain-Barr? Syndrome Product Offerings
Table 53. Kedrion Guillain-Barr? Syndrome Revenue (US$, Mn), (2017-2022)
Table 1. Guillain-Barr? Syndrome Market Opportunities & Trends in Global Market
Table 2. Guillain-Barr? Syndrome Market Drivers in Global Market
Table 3. Guillain-Barr? Syndrome Market Restraints in Global Market
Table 4. Key Players of Guillain-Barr? Syndrome in Global Market
Table 5. Top Guillain-Barr? Syndrome Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Guillain-Barr? Syndrome Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Guillain-Barr? Syndrome Revenue Share by Companies, 2017-2022
Table 8. Global Companies Guillain-Barr? Syndrome Product Type
Table 9. List of Global Tier 1 Guillain-Barr? Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Guillain-Barr? Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Guillain-Barr? Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Guillain-Barr? Syndrome Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Guillain-Barr? Syndrome Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Guillain-Barr? Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Guillain-Barr? Syndrome Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Guillain-Barr? Syndrome Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Guillain-Barr? Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Guillain-Barr? Syndrome Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Guillain-Barr? Syndrome Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Guillain-Barr? Syndrome Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Guillain-Barr? Syndrome Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Guillain-Barr? Syndrome Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Guillain-Barr? Syndrome Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Guillain-Barr? Syndrome Revenue, (US$, Mn), 2023-2028
Table 30. Grifols Corporate Summary
Table 31. Grifols Guillain-Barr? Syndrome Product Offerings
Table 32. Grifols Guillain-Barr? Syndrome Revenue (US$, Mn), (2017-2022)
Table 33. CSL Behring Corporate Summary
Table 34. CSL Behring Guillain-Barr? Syndrome Product Offerings
Table 35. CSL Behring Guillain-Barr? Syndrome Revenue (US$, Mn), (2017-2022)
Table 36. Octapharma Corporate Summary
Table 37. Octapharma Guillain-Barr? Syndrome Product Offerings
Table 38. Octapharma Guillain-Barr? Syndrome Revenue (US$, Mn), (2017-2022)
Table 39. Nihon Pharmaceutical Corporate Summary
Table 40. Nihon Pharmaceutical Guillain-Barr? Syndrome Product Offerings
Table 41. Nihon Pharmaceutical Guillain-Barr? Syndrome Revenue (US$, Mn), (2017-2022)
Table 42. Akari Therapeutics Corporate Summary
Table 43. Akari Therapeutics Guillain-Barr? Syndrome Product Offerings
Table 44. Akari Therapeutics Guillain-Barr? Syndrome Revenue (US$, Mn), (2017-2022)
Table 45. China Biologic Products Holdings Corporate Summary
Table 46. China Biologic Products Holdings Guillain-Barr? Syndrome Product Offerings
Table 47. China Biologic Products Holdings Guillain-Barr? Syndrome Revenue (US$, Mn), (2017-2022)
Table 48. Biotest Corporate Summary
Table 49. Biotest Guillain-Barr? Syndrome Product Offerings
Table 50. Biotest Guillain-Barr? Syndrome Revenue (US$, Mn), (2017-2022)
Table 51. Kedrion Corporate Summary
Table 52. Kedrion Guillain-Barr? Syndrome Product Offerings
Table 53. Kedrion Guillain-Barr? Syndrome Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Guillain-Barr? Syndrome Segment by Type in 2021
Figure 2. Guillain-Barr? Syndrome Segment by Application in 2021
Figure 3. Global Guillain-Barr? Syndrome Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Guillain-Barr? Syndrome Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Guillain-Barr? Syndrome Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Guillain-Barr? Syndrome Revenue in 2021
Figure 8. By Type - Global Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
Figure 9. By Application - Global Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
Figure 10. By Region - Global Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
Figure 11. By Country - North America Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
Figure 12. US Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
Figure 16. Germany Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 17. France Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
Figure 24. China Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 28. India Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
Figure 30. Brazil Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
Figure 33. Turkey Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 37. Grifols Guillain-Barr? Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. CSL Behring Guillain-Barr? Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Octapharma Guillain-Barr? Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Nihon Pharmaceutical Guillain-Barr? Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Akari Therapeutics Guillain-Barr? Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. China Biologic Products Holdings Guillain-Barr? Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Biotest Guillain-Barr? Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Kedrion Guillain-Barr? Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Guillain-Barr? Syndrome Segment by Type in 2021
Figure 2. Guillain-Barr? Syndrome Segment by Application in 2021
Figure 3. Global Guillain-Barr? Syndrome Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Guillain-Barr? Syndrome Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Guillain-Barr? Syndrome Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Guillain-Barr? Syndrome Revenue in 2021
Figure 8. By Type - Global Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
Figure 9. By Application - Global Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
Figure 10. By Region - Global Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
Figure 11. By Country - North America Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
Figure 12. US Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
Figure 16. Germany Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 17. France Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
Figure 24. China Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 28. India Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
Figure 30. Brazil Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Guillain-Barr? Syndrome Revenue Market Share, 2017-2028
Figure 33. Turkey Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Guillain-Barr? Syndrome Revenue, (US$, Mn), 2017-2028
Figure 37. Grifols Guillain-Barr? Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. CSL Behring Guillain-Barr? Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Octapharma Guillain-Barr? Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Nihon Pharmaceutical Guillain-Barr? Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Akari Therapeutics Guillain-Barr? Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. China Biologic Products Holdings Guillain-Barr? Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Biotest Guillain-Barr? Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Kedrion Guillain-Barr? Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
